Skip to content
Search

Latest Stories

Record two million people at risk of developing Type 2 diabetes

Around two million people in England are at risk of developing Type 2 diabetes, according to the latest NHS figures.

The statistics, published today, show a total of 1,969,610 people registered with a GP have non-diabetic hyperglycaemia, a condition which puts people at high risk of Type 2, which is the highest figure since records began.


NHS England warns of an even greater threat citing the growing obesity crisis that is exposing millions more to the condition.

“Our bulging waistlines mean two million people are now at risk of joining the expanding ranks of those living with largely preventable Type 2 diabetes,” said Sir Simon Stevens, NHS chief executive.

“The NHS’s highly successful, world-leading diabetes prevention programme is helping hundreds of thousands of people take small common-sense steps to get control of their own health. But unless many more of us make a change, obesity-related illnesses will end up costing hundreds of thousands of more lives and billions of pounds in higher treatment costs,” he added.

NHS is ramping up its effort to treat, prevent and even put the illness in remission as part of the Long Term Plan.

The world-first Diabetes Prevention Programme which identifies people at high risk of diabetes and supports them in living a healthier lifestyle has had around half a million referrals.

In April, NHS will roll out radical low-calorie diets, that have been shown to stamp out recently diagnosed Type 2 diabetes. This will be followed by a further nine months of support to help maintain weight loss.

Around nine out of 10 people with diabetes have Type 2 and there were over a million obesity diagnoses in hospital admissions last year, 884,000 the year before.

The growing number of people with diabetes may result in nearly 39,000 extra people suffering a heart attack in 2035, over 50,000 experiencing a stroke, while one in six hospital beds not occupied with someone with diabetes.

NHS national clinical director for obesity and diabetes, Professor Jonathan Valabhji said: “As these stark figures show it is wrong to think that the obesity and diabetes crisis is limited to those in middle and old age – there around 115,000 younger people suffering Type 2 diabetes or at risk of developing the condition.”

“The NHS Long Term Plan sets out the part we are playing to tackle the situation including piloting low-calorie diets to achieve Type 2 diabetes remission and doubling capacity of our world-leading NHS Diabetes Prevention Programme that can prevent people developing in the first place,” he added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less